Altropane I-123

DB15144InvestigationalSmall molecule

Altropane I-123 is under investigation in clinical trial NCT01950468 (A Cross-Over, Multi-Center Trial to Evaluate the Diagnostic Efficacy and Safety of [123I]NAV5001 as an Imaging Agent to Aid in the...

Formula / weight: C₁₈H₂₁FINO₂ · 425.275 g/mol (avg)
Code names: NAV5001

Resolves to

Compound

UNIID20OLL8HWUCAS208517-65-1

Structure

InChIKeyGTQLIPQFXVKRKJ-HYRAKNMCSA-NSMILESCOC(=O)[C@@H]1[C@H]2CC[C@@H](C[C@@H]1C1=CC=C(F)C=C1)N2C\C=C\[123I]

What you can answer from here — as of April 23, 2025

2Clinical trialsPhase, status and sponsor resolved per trial

Which companies are running trials of Altropane I-123, in which indications and phases, and which of those programs are still active?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account